Literature DB >> 12592099

Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia.

Peter Kienle1, Klaus Buhl, Christian Kuntz, Markus Düx, Christine Hartmann, Benner Axel, Christian Herfarth, Thomas Lehnert.   

Abstract

BACKGROUND: Local and multimodal therapeutic strategies for tumours of the oesophagus and gastric cardia, require precise preoperative staging. Endosonography is considered the most accurate staging method, while computed tomography (CT) has limitations especially in the evaluation of local infiltration. Macroscopic endoscopic evaluation was reported to be accurate in selected series, but no study has yet compared all three staging modalities.
METHODS: One hundred and seventeen unselected patients with tumours of the oesophagus and gastric cardia were prospectively staged first by the endoscopic macroscopic appearance and then by endosonography. All patients had preoperative CT scans, however, only the 36 patients receiving the scans at our institution were included in the study. The preoperative staging results were then compared to postoperative histology which was available as the gold standard in all included patients. Kappa statistics were used to exclude chance agreement of the clinical staging results with the pathohistological findings. Differences between the resulting kappa values for the different staging modalities were analysed with a jack-knife test.
RESULTS: Endoscopic macroscopic staging and endosonography (accuracy 67 and 69%, weighted kappa 0.78 and 0.84) were significantly more accurate than CT (accuracy 33%, weighted kappa 0.44) for determination of the T category (p = 0.006 and p = 0.001). After exclusion of tumours of the cardia (n = 33), the accuracy of macroscopic and endosonographic staging (accuracy 72 and 75%, weighted kappa 0.86 and 0.88) increased and remained more accurate than CT (accuracy 50%, weighted kappa 0.62). The main pitfall in our series in staging the T category was the overestimation of T2 tumours in the cardia as T3 or even as T4 tumours due to the inability to visualise the serosa. The accuracy of predicting lymph node metastasis was 68% for macroscopic endoscopic, 79% for endosonographic, and 67% for CT staging. Only endosonographic staging was significantly different from chance agreement with histology (weighted kappa = 0.56). Endosonographic staging was significantly more accurate than endoscopic macroscopic and CT staging (p = 0.03).
CONCLUSIONS: Endosonography is the most accurate staging modality for overall preoperative staging of oesophageal and cardial tumours. Endoscopic macroscopic staging allows a reasonably accurate assessment of the T category. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12592099     DOI: 10.1159/000068360

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

1.  Medical image analysis: computer-aided diagnosis of gastric cancer invasion on endoscopic images.

Authors:  Keisuke Kubota; Junko Kuroda; Masashi Yoshida; Keiichiro Ohta; Masaki Kitajima
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

Review 2.  Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review.

Authors:  Srinivas-R Puli; Jyotsna-Bk Reddy; Matthew-L Bechtold; Daphne Antillon; Jamal-A Ibdah; Mainor-R Antillon
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 3.  Endoscopic ultrasound: it's accuracy in evaluating mediastinal lymphadenopathy? A meta-analysis and systematic review.

Authors:  Srinivas-R Puli; Jyotsna Batapati Krishna Reddy; Matthew-L Bechtold; Jamal-A Ibdah; Daphne Antillon; Shailender Singh; Mojtaba Olyaee; Mainor-R Antillon
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

4.  Intraoperative endoscopy in obstructive hypopharyngeal carcinoma.

Authors:  Predrag Pesko; Milos Bjelovic; Predrag Sabljak; Dejan Stojakov; Ebrahimi Keramatollah; Dejan Velickovic; Bratislav Spica; Branka Nenadic; Aleksandra Djuric-Stefanovic; Djordjije Saranovic; Vera Todorovic
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.

Authors:  Karim Sillah; Luke R Williams; Hans-Ulrich Laasch; Azeem Saleem; Gillian Watkins; Susan A Pritchard; Patricia M Price; Catharine M West; Ian M Welch
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

6.  CT and MR imaging for detecting neoplastic invasion of esophageal inlet.

Authors:  Bin Chen; Shan-Kai Yin; Qi-Xin Zhuang; Ying-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

7.  Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer.

Authors:  Jing-Ping Yu; Su-Ping Sun; Zhi-Qiang Sun; Xin-Chu Ni; Jian Wang; Yi Li; Li-Jun Hu; Dong-Qing Li
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 8.  Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.

Authors:  Simone Mocellin; Sandro Pasquali
Journal:  Cochrane Database Syst Rev       Date:  2015-02-06

9.  Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.

Authors:  Tomoya Yokota; Hiroyasu Igaki; Ken Kato; Yasuhiro Tsubosa; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Haruhiko Fukuda; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2015-09-03       Impact factor: 3.402

10.  Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer.

Authors:  E P M van Vliet; J J Hermans; W De Wever; M J C Eijkemans; E W Steyerberg; C Faasse; E P M van Helmond; A M de Leeuw; A C Sikkenk; A R de Vries; E H de Vries; E J Kuipers; P D Siersema
Journal:  Eur Radiol       Date:  2008-06-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.